HAVCR2 and neoplasm: Although TIM-3 was initially thought to be a sign of dysfunctional T-cells, it has been demonstrated that TIM-3 is highly expressed on several types of immune cells, particularly myeloid cells, and that myeloid cells might play a predominant role in TIM-3-mediated anti-tumor immunity [21,26,27,28,29].